| 12319671 |
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof |
Hua Zhou, John J. Acton, III, Michael J. Ardolino, Yi-Heng Chen, Peter H. Fuller +15 more |
2025-06-03 |
| 12030872 |
N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof |
William P. Kaplan, John J. Acton, III, Michael J. Ardolino, Joanna L. Chen, Peter H. Fuller +10 more |
2024-07-09 |
| 11174248 |
Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof |
John J. Acton, III, David A. Candito, J. Michael Ellis, Peter H. Fuller, Hakan Gunaydin +6 more |
2021-11-16 |
| 11161854 |
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof |
David A. Candito, Thomas H. Graham, John J. Acton, III, Ryan Chau, Joanna L. Chen +13 more |
2021-11-02 |
| 10745364 |
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease |
Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more |
2020-08-18 |
| 10377768 |
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease |
Thomas D. Aicher, Kenneth J. Barr, Blair T. Lapointe, Karin Ann Stein, William D. Thomas +3 more |
2019-08-13 |
| 10221146 |
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease |
Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more |
2019-03-05 |
| 10221142 |
Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof |
Blair T. Lapointe, Peter H. Fuller, Hakan Gunaydin, Kun Liu, Nunzio Sciammetta +5 more |
2019-03-05 |
| 9809561 |
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease |
Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more |
2017-11-07 |
| 9783511 |
Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease |
Thomas D. Aicher, Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr +6 more |
2017-10-10 |
| 9663502 |
2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease |
Thomas D. Aicher, Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more |
2017-05-30 |
| 9657033 |
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease |
Thomas D. Aicher, Kenneth J. Barr, Blair T. Lapointe, Karin Ann Stein, William D. Thomas +3 more |
2017-05-23 |
| 9266827 |
Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease |
Thomas D. Aicher, Kenneth J. Barr, William D. Thomas, Peter L. Toogood, Chad A. Van Huis |
2016-02-23 |
